1
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Monoclonal Antibodies as Prognostic Indicators in Patients with Squamous Cancer of the Oral Cavity and Oral Pharynx

, , , , , & show all
Pages 229-234 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

K. J. A. Kairemo & E. V. M. Hopsu. (1990) Immunoscintigraphy in Laryngeal and Pharyngeal Carcinomas Using Indium-111 Labelled Monoclonal Antibody. Acta Oncologica 29:4, pages 533-538.
Read now

Articles from other publishers (4)

Takuji Tanaka. (1995) Chemoprevention of oral carcinogenesis. European Journal of Cancer Part B: Oral Oncology 31:1, pages 3-15.
Crossref
Marcel P. Copper, Boudewijn J. M. Braakhuis, Nico de Vries, Guus A. M. S. Van Dongen, Jos J. P. Nauta & Gordon B. Snow. (1993) A panel of biomarkers of carcinogenesis of the upper aerodigestive tract as potential intermediate endpoints in chemoprevention trials. Cancer 71:3, pages 825-830.
Crossref
Magne Bryne. (2006) Prognostic value of various molecular and cellular features in oral squamous cell carcinomas: a review. Journal of Oral Pathology & Medicine 20:9, pages 413-420.
Crossref
E. Dabelsteen, H. Clausen & U. Mandel. (1991) Aberrant glycosylation in oral malignant and premalignant lesions. Journal of Oral Pathology and Medicine 20:8, pages 361-368.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.